Moreover, CRISPR/Cas9-mediated deletion of Cdh1 (Supplementary Fig. 1d) escalated Src activity in breast cancer cells (Fig. 1d and Supplementary Fig. 1e, f). This evidence concerns the gene CDH1 and breast cancer.